Ingredients and Regulatory Highlights of 2020

Ingredients and Regulatory Highlights of 2020

2020 was definitely an atypical year. The COVID-19 pandemic has created tremendous challenges to the industry, who had to adapt fast to the current health challenges. Also, several conferences and trade shows had to be cancelled or postponed. Thus, home office work...
Impact of COVID-19 on clinical research

Impact of COVID-19 on clinical research

In a collaboration with Vitafoods Insights, our Head of clinical research, Felix Alt, wrote an article about the impact of COVID-19 on clinical research in consumer healthcare, where he talks about the challenges and disruptions clinical research organizations (CROs)...
Nutrition Capital Network – Europe Investor Meeting invitation

Nutrition Capital Network – Europe Investor Meeting invitation

The NCN 2020 Europe Investor Meeting connects companies in science, technology, and ingredients with investment, licensing, and corporate partnerships. Their next event will be hosted virtually and applications are still open. Interested? Then click here to know more...
CBD – no longer considered a narcotic

CBD – no longer considered a narcotic

In a recent ruling, the European Court of Justice (ECJ) (Case C-663/18) decided that extracts of the hemp plant – the varieties with low THC content – are not classified as narcotics. This re-opens the path for CBD extract products for non-medicinal...